Form 8-K - Current report:
SEC Accession No. 0001628280-25-032155
Filing Date
2025-06-18
Accepted
2025-06-18 16:50:11
Documents
15
Period of Report
2025-06-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-20250618.htm   iXBRL 8-K 47243
2 EX-3.1 c4t-certificateofamendme.htm EX-3.1 1443
6 c4t-certificateofamendme001.jpg GRAPHIC 70850
7 c4t-certificateofamendme002.jpg GRAPHIC 141242
  Complete submission text file 0001628280-25-032155.txt   466405

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20250618.xsd EX-101.SCH 1829
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20250618_lab.xml EX-101.LAB 23451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20250618_pre.xml EX-101.PRE 13623
17 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20250618_htm.xml XML 3015
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 251057568
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)